At 40 weeks, all three doses (3 mg, 12 mg, 36 mg) of orforglipron achieved the primary endpoint of superior A1C reduction compared to placebo , lowering A1C by 1.3% to 1.6% from a baseline of 8.0% , with improvements seen as early as 4 weeks
Use each product separately with 1-2 week intervals of one another
In comparison, IGF-1 LR3 is not studied in humans, and there is a risk of dangerous side effects.
Your pancreas doesnt have to work as hard to release insulin
From a purely theoretical time stand point (not taking the 80% discharge rule into account), this equals 500 mAh of draw per minute, so the 1000 mAh pack would be completely exhausted in about 2 minutes if it's exposed to that maximum rated 30C (30A) discharge rate the entire time
But the drugs have also been a lifeline for hundreds of thousands of Medi-Cal patients with obesity, who could now regress on their weight-loss